DE122009000010I2 - Krampflösende, enantiomere aminosäure-derivate - Google Patents

Krampflösende, enantiomere aminosäure-derivate

Info

Publication number
DE122009000010I2
DE122009000010I2 DE122009000010C DE122009000010C DE122009000010I2 DE 122009000010 I2 DE122009000010 I2 DE 122009000010I2 DE 122009000010 C DE122009000010 C DE 122009000010C DE 122009000010 C DE122009000010 C DE 122009000010C DE 122009000010 I2 DE122009000010 I2 DE 122009000010I2
Authority
DE
Germany
Prior art keywords
enantiomic
crampoles
amino acid
acid derivatives
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE122009000010C
Other languages
German (de)
English (en)
Other versions
DE122009000010I1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Technologies Inc
Original Assignee
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21760388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122009000010(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Research Corp Technologies Inc filed Critical Research Corp Technologies Inc
Publication of DE122009000010I1 publication Critical patent/DE122009000010I1/de
Publication of DE122009000010I2 publication Critical patent/DE122009000010I2/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE122009000010C 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate Active DE122009000010I2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1352296P 1996-03-15 1996-03-15
PCT/US1997/004579 WO1997033861A1 (en) 1996-03-15 1997-03-17 Anticonvulsant enantiomeric amino acid derivatives

Publications (2)

Publication Number Publication Date
DE122009000010I1 DE122009000010I1 (de) 2009-05-20
DE122009000010I2 true DE122009000010I2 (de) 2010-10-21

Family

ID=21760388

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69705210T Expired - Lifetime DE69705210T2 (de) 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate
DE122009000010C Active DE122009000010I2 (de) 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate
DE69729392T Expired - Lifetime DE69729392T2 (de) 1996-03-15 1997-03-17 Krampfhemmende enantiomere Aminosäurederivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69705210T Expired - Lifetime DE69705210T2 (de) 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69729392T Expired - Lifetime DE69729392T2 (de) 1996-03-15 1997-03-17 Krampfhemmende enantiomere Aminosäurederivate

Country Status (12)

Country Link
EP (2) EP1038522B1 (enExample)
JP (1) JP3145414B2 (enExample)
AT (2) ATE202079T1 (enExample)
AU (1) AU718577B2 (enExample)
CA (1) CA2248317C (enExample)
DE (3) DE69705210T2 (enExample)
DK (2) DK1038522T3 (enExample)
ES (2) ES2157567T3 (enExample)
FR (1) FR09C0006I2 (enExample)
NL (1) NL300376I1 (enExample)
PT (2) PT888289E (enExample)
WO (1) WO1997033861A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048899A (en) * 1997-03-17 2000-04-11 Research Corporation Tech., Inc. Anticonvulsant enantiomeric amino acid derivatives
EP1642889A1 (en) 2004-10-02 2006-04-05 Schwarz Pharma Ag Improved synthesis scheme for lacosamide
EP1873527A1 (en) 2006-06-30 2008-01-02 Schwarz Pharma Ag Method for identifying CRMP modulators
US8093426B2 (en) 2007-12-04 2012-01-10 Ranbaxy Laboratories Limited Intermediate compounds and their use in preparation of lacosamide
DE102008059155A1 (de) 2008-11-27 2010-06-02 Ratiopharm Gmbh Trockenverarbeitung und neue Formen von Lacosamid
EP2462107A1 (en) 2009-08-06 2012-06-13 Medichem, S.A. Solid forms of an n-(phenylmethyl)propanamide derivative and processes of preparation
JP5564570B2 (ja) * 2009-09-25 2014-07-30 カディラ・ヘルスケア・リミテッド ラコサミドおよびその中間体の調製方法
IT1398044B1 (it) * 2010-01-29 2013-02-07 Archimica Srl Processo per la preparazione della lacosamide
EP2534128A1 (en) 2010-02-08 2012-12-19 Natco Pharma Limited A process for the preparation of lacosamide
WO2011099033A1 (en) * 2010-02-09 2011-08-18 Msn Laboratories Limited Process for preparing (r)-2-acetamido-n-benzyl-3-methoxy-propionamide
EP2399901A1 (en) 2010-06-23 2011-12-28 Archimica GmbH Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide
EP2621893A1 (en) 2010-10-01 2013-08-07 UCB Pharma GmbH Process for the preparation of amino acid derivatives
WO2012051551A1 (en) * 2010-10-15 2012-04-19 Nektar Therapeutics N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
PL2444390T3 (pl) 2010-10-19 2017-06-30 Euticals Gmbh Sposób wytwarzania Lakozamidu
EP2645997B1 (en) 2010-12-02 2022-08-10 UCB Pharma GmbH Once daily formulation of lacosamide
EP2468261A1 (en) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation of lacosamide
CN104771356A (zh) * 2014-01-09 2015-07-15 山东方明药业集团股份有限公司 一种拉科酰胺注射液及其制备方法
US11278634B1 (en) 2021-02-12 2022-03-22 Extrovis Ag Stable parenteral composition of lacosamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3678469D1 (de) * 1985-02-15 1991-05-08 Res Corp Technologies Inc Aminosaeure-derivate und ihre anwendung zur herstellung eines antikrampfmittels.
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant

Also Published As

Publication number Publication date
FR09C0006I2 (fr) 2009-12-18
AU2539497A (en) 1997-10-01
FR09C0006I1 (enExample) 2009-04-17
WO1997033861A1 (en) 1997-09-18
EP0888289B1 (en) 2001-06-13
EP1038522A3 (en) 2003-01-15
DK0888289T3 (da) 2001-09-03
DE69729392T2 (de) 2005-06-02
ES2157567T3 (es) 2001-08-16
CA2248317C (en) 2003-12-02
AU718577B2 (en) 2000-04-13
ATE268169T1 (de) 2004-06-15
EP1038522A2 (en) 2000-09-27
PT888289E (pt) 2001-09-28
JP2000505476A (ja) 2000-05-09
NL300376I1 (nl) 2009-05-06
CA2248317A1 (en) 1997-09-18
DE69729392D1 (de) 2004-07-08
DE122009000010I1 (de) 2009-05-20
DK1038522T3 (da) 2004-10-11
ES2218024T3 (es) 2004-11-16
DE69705210T2 (de) 2001-09-20
JP3145414B2 (ja) 2001-03-12
ATE202079T1 (de) 2001-06-15
DE69705210D1 (de) 2001-07-19
EP1038522B1 (en) 2004-06-02
EP0888289A1 (en) 1999-01-07
PT1038522E (pt) 2004-10-29

Similar Documents

Publication Publication Date Title
NL300376I1 (nl) Enantiomere anticonvulsieaminozuurderivaten
FI941378A0 (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
BR9808281A (pt) Compostos, composições farmacêuticas, processo para tratar doenças proliferativas e/ou distúrbios do sistema imune e para preparar um composto, e, uso de um composto
EA199900620A1 (ru) Фталазиноны
PT94925A (pt) Processo para a preparacao de derivados de tiazol e de composicoes farmaceuticas que os contem
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ES552348A0 (es) Procedimiento de preparar agentes anticonvulsivos derivados de aminoacidos
ES2126075T3 (es) Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa.
ATE399545T1 (de) Mittel zur verringerung der eigeweidefette
EP1034783A4 (en) AMIDE DERIVATIVES
ATE264104T1 (de) Immunmodulierende arzneimittelzusammenstellung
DK526087D0 (da) Antikonvulsive aminosyrederivater
DK498889A (da) Substituerede aromatiske forbindelser med virkning paa centralnervesystemet
EA199900888A1 (ru) Противоревматические средства
FI963568A0 (fi) Peptidijohdannaisia
DE69123757D1 (de) Epoxysuccinamidsäurederivat
ES2171389T3 (es) Derivados anticonvulsivos de aminoacidos.
FI965157A7 (fi) 2-((2,6-dikloorifenyyli)amiini)fenyyliasetoksietikkahapon uudet suolat orgaanisten emäksisten kationien kanssa
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
DE69014261D1 (de) N-Azabicyclo[3.3.0]octanamide von aromatischen Säuren.
PT88242A (pt) Processo para a preparacao de eteres e tioeteres tendo actividade terapeutica
BR9506763A (pt) Derivados de carbamoil metil uréia
DE69622393D1 (de) Neue verwendung von pyrazolopyridinverbindungen
ATE48511T1 (de) M-cyanphenethanolamine als tierwachstumsfoerderer und antilipogene mittel.
EA200101043A1 (ru) Способ лечения неврологических или нейропсихиатрических расстройств